ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.954,09
-0,37%
S&P 500
5.399,22
-0,51%
US Dollar vs BRL
5,6448
-0,18%
Bitcoin
65.704,08
0,51%
Brent Oil
81,535
0,99%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Bionik Laboratories Corporation (CE) (BNKL)

  7. Bionik Laboratories Corporation (CE) (BNKL) Notícias

BNKL

Bionik Laboratories (CE) (BNKL)

Bionik Laboratories Corporation (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:BNKL
DataHoraFonteTítuloCódigoCompanhia
30/06/202317:31Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202318:05Edgar (US Regulatory)Annual Report (10-k)USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202311:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
16/06/202309:56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
08/02/202310:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
07/12/202213:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:BNKLBionik Laboratories Corporation (CE)
07/12/202213:27Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BNKLBionik Laboratories Corporation (CE)
04/11/202217:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:BNKLBionik Laboratories Corporation (CE)
25/10/202212:28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BNKLBionik Laboratories Corporation (CE)
27/05/202214:31Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:BNKLBionik Laboratories Corporation (CE)
01/06/202015:17Edgar (US Regulatory)Specialized Disclosure Report (sd)USOTC:BNKLBionik Laboratories Corporation (CE)
21/02/202019:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:BNKLBionik Laboratories Corporation (CE)
13/02/202014:17Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:BNKLBionik Laboratories Corporation (CE)
13/11/201908:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:BNKLBionik Laboratories Corporation (CE)
12/11/201917:58Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:BNKLBionik Laboratories Corporation (CE)
28/10/201911:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:BNKLBionik Laboratories Corporation (CE)
16/09/201918:26Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:BNKLBionik Laboratories Corporation (CE)
18/03/201907:05Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:BNKLBionik Laboratories Corporation (CE)
11/02/201919:21Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement...USOTC:BNKLBionik Laboratories Corporation (CE)
16/10/201818:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:BNKLBionik Laboratories Corporation (CE)
17/08/201818:15Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:BNKLBionik Laboratories Corporation (CE)
10/08/201818:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:BNKLBionik Laboratories Corporation (CE)
07/08/201818:36Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:BNKLBionik Laboratories Corporation (CE)
15/06/201815:38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:BNKLBionik Laboratories Corporation (CE)
05/10/201718:27Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:BNKLBionik Laboratories Corporation (CE)
05/10/201715:30Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)USOTC:BNKLBionik Laboratories Corporation (CE)
03/08/201718:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:BNKLBionik Laboratories Corporation (CE)
14/07/201718:29Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:BNKLBionik Laboratories Corporation (CE)
12/07/201717:27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:BNKLBionik Laboratories Corporation (CE)
30/06/201718:08Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)USOTC:BNKLBionik Laboratories Corporation (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:BNKL

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
JFEN3
JOAO FORTES ON
BOV
AZEV4
AZEVEDO PN
BOV
COGN3
COGNA ON
BOV
AMBP3
Ambipar Participacoes e ... ON
BOV
ETER3
ETERNIT ON
BOV
AMER3
Americanas ON
BOV
HAGA3
HAGA ON
BOV
TELB4
TELEBRAS PN
BOV
PDGR3
PDG REALT ON
BOV
GOLL4
GOL PN
BOV
PRIO3
PETRORIO ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
BAZA3
AMAZONIA ON
BOV
MEAL3
IMC S/A ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados